OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

[News]

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today summarized new data highlighting the progress of OncoMed's pipeline of anti-cancer biologics presented this week in an oral presentation and five posters at the Annual Meeting of the American Association of Cancer Research in Washington, DC.

More... (http://www.news-medical.net/news/20130411/OncoMed-highlights-progress-of-anti-cancer-biologics-at-AACR-annual-meeting.aspx)